GT Biopharma (GTBP) had the highest return between 2011 and 2012 by a US stock in the Nasdaq Composite (IXIC), returning 525,310,195%.

ASSET	YEARS	% RETURN
GT Biopharma (GTBP)	2011-2012	525,310,195.03%
INVO Fertility (IVF)	2011-2012	107,900.04%
Nixxy (NIXX)	2011-2012	64,900%
Xpel (XPEL)	2011-2012	1,177.78%
Kazia Therapeutics Ltd ADR (KZIA)	2011-2012	1,078.12%
Natural Health Trend (NHTC)	2011-2012	1,020.81%
Versus Systems Inc. (VS)	2011-2012	940%
Heritage Global (HGBL)	2011-2012	816.67%
Patrick Industries (PATK)	2011-2012	674.17%
Barfresh Food (BRFH)	2011-2012	670%
Where Food Comes From (WFCF)	2011-2012	556.24%
Coda Octopus (CODA)	2011-2012	514.62%
Expedia (EXPE)	2011-2012	512.32%
Mawson Infrastructure (MIGI)	2011-2012	500%
Precision Optics Corporation, Inc Common stock (POCI)	2011-2012	466.67%
Lifevantage (LFVN)	2011-2012	461.53%
Regeneron Pharmaceuticals (REGN)	2011-2012	423.31%
Usio (USIO)	2011-2012	420%
Security National Financial (SNFCA)	2011-2012	379.2%
Aemetis (AMTX)	2011-2012	366.67%
Netcapital (NCPL)	2011-2012	366.67%
OLB (OLB)	2011-2012	326.83%
Turtle Beach (TBCH)	2011-2012	317.58%
Consumer Portfolio Services (CPSS)	2011-2012	315.5%
Imunon (IMNN)	2011-2012	295.65%